Journal of Psychology & Psychotherapy
Open Access
ISSN: 2161-0487
+44 1478 350008
ISSN: 2161-0487
+44 1478 350008
Ashwin Singh Chouhan
B. N. University (Department of Pharmaceutical Science), India
Keynote: J Psychol Psychother
Psychopharmacology has long been seen as essential to mental health care prevention, usually in terms of preventing relapse. There are mental states that have been uncovered in recent decades that precede full-threshold illnesses. These conditions, sometimes referred to as "at-risk" states, frequently affect young individuals in their early teens to mid-20s. In an effort to prevent or at least postpone the emergence of full-threshold disorders and facilitate long-term functional gains, this has led to a notable increase in research interest in the use of psychopharmacological therapies in at-risk mental states. With an emphasis on secondary suggested prevention in "at-risk" mental states, we give an overview of the connections between psychopharmacology and prevention in mental health care in the current section. Research has looked at the use of drugs that are known to be helpful in treating full-threshold illnesses; however, these studies are frequently underpowered and emphasize the difficulties in treating recognized adverse effects in patients who do not yet have full-threshold disorders. In the context of a growing illness, more recent research investigates the use of pharmacology to accomplish neuroprotection as well as the prescription of "nutraceuticals," which are safe substances with few adverse effects that may safeguard neuronal development. With special attention to how they can affect future research directions, the practical and ethical aspects of dealing with youth in "at-risk" situations and psychopharmacological therapies in general are also covered. The treatment of psychosis, depression, and other mental health issues was completely transformed when psychopharmacological therapies were introduced in the late 1940s. Pharmacotherapy, like many other aspects of healthcare, frequently requires long-term maintenance treatment with the goal to maintain health and avoid recurrence. Throughout history, mental health nurses have played a significant part in medication management by supporting patients in controlling their treatment plans to best suit their needs and lifestyle while also optimizing their health. The medical therapies for mental health issues will be covered in this section, along with best practices based on the most recent research
Ashwin Singh Chouhan is a distinguished academic affiliated with the Department of Pharmaceutical Science at B.N. University, Udaipur, Rajasthan, India. His expertise lies in advancing pharmaceutical research and education. With a passion for innovation, he has contributed significantly to the field through publications and presentations. Dedicated to shaping future pharmacists, he actively mentors students and collaborates on research initiatives. Ashwin's work reflects a commitment to improving healthcare through scientific excellence